Vaccines Just read an article on the Pfizer logistics given the need to keep the vaccine at -70 degree temperature. Sounds like client countries will also stand in line for purchasing all the refrigeration equipment to be able to distribute it. It will be a bit messy, but as Paul says, the sales pitch is not that BioCloud is a replacement for any of the things available today but that it is a technology that is part of the safe space toolkit for covid AND other viruses, after adaptation. And I imagine there is a rush to get it out there but over time it will evolve in many ways such as mutli-virus detection cartridges, increase in area coverage, reduction in costs, etc, etc that will further popularize the safe space notion and make it part of the new normal. This is all consistent with Paul's longer term vision for the company and not focusing on a quick flip. All we can do is wait to see this unfold. We are at a point where any day we could see a good newsrelease.